BioMarin Pharmaceutical Inc (BMRN) Shareholders’ equity 2016–2025
BioMarin Pharmaceutical Inc (BMRN) shareholders’ equity at each fiscal year-end, per SEC filings.
$6.1BFY2025 · since FY2016: $2.8B → $6.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $6.1B | +7.6% |
| FY2024 | $5.7B | +14.3% |
| FY2023 | $5.0B | +7.6% |
| FY2022 | $4.6B | +7.9% |
| FY2021 | $4.3B | +4.0% |
| FY2020 | $4.1B | +31.3% |
| FY2019 | $3.1B | +5.2% |
| FY2018 | $3.0B | +5.7% |
| FY2017 | $2.8B | +1.5% |
| FY2016 | $2.8B | — |
Source: SEC XBRL filings · For reference only · Not investment advice